Policy Brief Understanding the implementation of Pre-Exposure Prophylaxis (PrEP) to prevent HIV in California January 1, 2011 Scientists announced the results of the iPrex trial in November 2010, showing that overall, a daily dose of Truvada, a combination of two oral antiretroviral drugs, tenofovir disoproxil fumarate and emtricitabine, reduced HIV infection in a sample of […]
Read More